Delaney Mark E's Form 4 filing
Quest Diagnostics Inc (DGX) · filed Jul 26, 2024
- Accession no.
- 0001022079-24-000168
- Filed
- Jul 26, 2024
- Trade date
- Jul 22-24, 2024
- Filing delay
- 4 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $60.1K. It was filed 4 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Delaney Mark ECIK 0001955265 | Officer (SVP & Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 22, 2024 | Common Stock | LLess common codeAcquired | +6 | $146.98 | +$881.88 | 5,439 | Direct | |
| Jul 24, 2024 | Common Stock | SSaleDisposed | −420 | $143.08 | −$60,093.6 | 5,019 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.